Name: UMIN ID:
Unique ID issued by UMIN | UMIN000037833 |
---|---|
Receipt number | R000043136 |
Scientific Title | All-Patient General Drug Use Surveillance of Rozlytrek Capsule - Advanced or recurrent solid tumors with NTRK gene fusions - |
Date of disclosure of the study information | 2019/09/04 |
Last modified on | 2024/01/15 14:27:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2019/08/28 15:36:43 | ||
2 | Update | 2019/09/04 15:28:08 | Recruitment status Date of IRB |
|
3 | Update | 2020/01/17 09:03:37 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
4 | Update | 2020/01/17 09:11:44 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2020/01/17 09:13:52 | Last follow-up date |
|
6 | Update | 2020/01/27 09:37:14 | Email |
|
7 | Update | 2020/02/26 09:13:56 | Email Organization1 |
|
8 | Update | 2020/02/26 09:16:19 | TEL |
|
9 | Update | 2020/02/26 09:31:34 | Address1 Tel1 Email1 |
|
10 | Update | 2022/01/07 13:01:30 | Division name Division name TEL Last name of contact person Last name of contact person Division name Division name TEL Division name Division name TEL |
|
11 | Update | 2022/01/07 13:09:55 | Email |
|
12 | Update | 2022/12/28 06:46:34 | Email |
|
13 | Update | 2023/05/30 17:08:19 | Email |
|
14 | Update | 2024/01/15 14:27:03 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |